搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
1 天
Key enzyme identified as potential target for cancer immunotherapy
Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, ...
Armed robbery in Revesby
1 天
A*STAR Finds New Cancer Immunotherapy Target
Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme – P4HA1 prolyl hydroxylase, is strongly induced in ...
EurekAlert!
2 天
A*STAR researchers identify potential novel target for cancer immunotherapy
Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme – P4HA1 prolyl hydroxylase ...
News Medical
3 天
PIN1 protein found to be a significant driver of bladder cancer
Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...
The Pharma Letter
4 天
Distribution deal for Vafseo in CEE region
Turkish drugmaker Er-Kim has signed a distribution agreement with Germany’s MEDICE Health Family to commercialize Vafseo ...
thecardiologyadvisor.com
4 天
2024 Novel Drug and Biological Product Approvals
The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.
manilatimes
5 天
Er-Kim Announces Exclusive Distribution Agreement with the MEDICE Health Family For Vafseo ...
Vafseo ® (vadadustat) is a once-daily oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor to treat anemia due ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈